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Abstract: 2-Bromophenyl salicylate is synthesized from 2-benzyloxybenzoic acid in two 
steps. The final compound has been characterized by IR, 1H-NMR, 13C-NMR and HRMS. 
The melting point for 2-bromophenyl salicylate is provided. 
Keywords: esterification; debenzylation; salicylate ester 
 
Derivatives of salicylic acids can be of great biological importance. Salicylate derivatives have been 
probed for their potential to mimic or exceed the effects of salicylic acid in its anti-inflammatory [1,2] 
and anti-thrombotic activities [3,4]. In addition, researchers have studied the derivatives’ anti-malarial [5], 
antifungal [6] and herbicidal activities [7,8] and the ability of salicylates to induce immunity to disease 
in plants [9,10]. Here in we report the synthesis of a new salicylate ester, 2-bromophenyl salicylate 2, 
in two steps beginning with commercially available 2-benzyloxybenzoic acid 1 (Scheme 1). The first 
step of the synthesis is a Steglich esterification with 1 and 2-bromophenol. This is followed by 
debenzylation of the resulting product with hydrogen gas and palladium catalyst to provide 2. 
Scheme 1. Synthesis of 2-bromophenyl salicylate 2. 
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Experimental 
General 
Unless noted, all reactions were performed under an atmosphere of argon in oven-dried glassware. 
Solvents for the reaction were obtained from commercial sources and purified with MBraun Manual 
Solvent Purification System prior to use. All other chemicals were obtained from commercial sources 
without further purification. Chromatography was performed with Selecto Scientific Si-gel (particle 
size 100–200 microns) and the chromatography solvents were purchased from commercial sources and 
used without further purification. All IR spectra were recorded on a Thermo Nicolet Avatar 370-FTIR. 
NMR spectra were recorded on a Bruker Multi-Nuclear NMR instrument, 1H-NMR: 250 MHz and 
13C-NMR: 63MHz; the solvent was CDCl3. The NMR signals are reported in parts per million (ppm) 
relative to the residual CHCl3 in the solvent. Signals are described with multiplicity, singlet (s), 
doublet (d), triplet (t), triplet of doublet (td) and multiplet (m); coupling constants (Hz) and integration. 
The melting point was measured with the Vernier Melt Station using Vernier LabQuest 2 and is 
uncorrected. High Resolution Mass Spectrometry was performed using Waters Micromass Q-Tof 
micro Mass Spectrometer, ESI, positive ion mode. 
2-Bromophenyl Salicylate (2) 
(a) An oven dried, round-bottom flask equipped with a stir bar and an argon inlet was charged with 
dichloromethane (50 mL), 2-bromophenol (0.59 mL, 5.05 mmol), N,N′-dicyclohexylcarbodiimide 
(DCC) (1.14 g, 5.50 mmol), 4-(N,N-dimethylamino)pyridine (DMAP) (122 mg, 1.00 mmol) and  
2-benzyloxybenzoic acid (1.14 g, 5.00 mmol). After stirring for 12 hours at room temperature, the 
resulting white precipitate was removed by vaccum filtration. The clear filtrate was concentrated under 
vacuum and the crude, yellow oil was purified by flash column chromatography (5% ethyl acetate in 
petroleum ether) to provide a colorless oil (1.86 g, 97%) [11]. 
(b) An oven dried, round-bottom flask equipped with a stir bar and an argon inlet was charged with 
the product from (a) (766.5 mg, 2.00 mmol) in tetrahydrofuran (THF) (20 mL) and 10% Pd/C catalyst 
(77 mg). The argon inlet was replaced with a hydrogen inlet and the black suspension was stirred 
under an atmosphere of hydrogen. After 24 h, the hydrogen inlet was removed and the suspension was 
filtered through a silica-plug (50% ethyl acetate in hexanes). The filtrate was concentrated under 
vacuum and resulting crude, a yellow solid, was purified by flash column chromatography (2% ethyl 
acetate in petroleum ether) to provide 2, a white solid (356 mg, 61%). M.p. 63.0–64.7 °C; FT-IR 
(ZnSe): 3210 (broad, OH), 1686, 1301, 1251, 1208, 1155, 1069, 755, 760, 697 cm−1; 1H-NMR δ 10.34 
(s, 1H, OH), 8.18 (dd, 1H, J = 1.5, 7.9 Hz), 7.71 (dd, 1H, J = 1.2, 7.9 Hz) 7.57 (td, 1H, J = 1.4, 7.1 Hz), 
7.41 (td, 1H, J = 1.4, 7.4 Hz), 7.21-7.33 (m, 2H), 7.09 (d, 1H, J = 8.8 Hz), 7.02 (d, 1H, J = 7.2 Hz); 
13C-NMR δ 167.8, 162.1, 147.6, 136.7, 133.5, 130.5, 128.5, 127.7, 123.7, 119.6, 117.8, 116.1, 111.3; 
HRMS (ESI, positive ion mode): [M+Na]+ m/z calculated: 314.9633, found: 314.9622. 
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